Lymphangioleiomyomatosis (LAM) Registry
Non-BioLINCC Resource: This resource is managed by the Study group. For information on obtaining specimens and/or data, follow the Study Website link below.
Clinical Trial URLs
Primary Publication URLs
Commercial Use Data Restrictions No
Data Restrictions Based On Area Of Research No
Commercial Use Specimen Restrictions No
Non-Genetic Use Specimen Restrictions Based On Area Of Use No
Genetic Use Of Specimens Allowed? Yes
Genetic Use Area Of Research Restrictions No
The LAM Registry was established to define the natural history and identify prognostic biomarkers to help guide management and decision-making in patients with LAM.
A LAM Registry was established at six centers by the NHLBI. LAM is a rare multi-system disease that can affect the lungs of young women, is of uncertain cause, is usually progressive, and can cause debilitating lung disease which may be corrected with lung transplantation. Several hundred women with the disease were identified, largely through a LAM Foundation in Cincinnati, Ohio.
Women with a lymphangioleiomyomatosis diagnosis, ages 18-76.
pulmonary lymphangioleiomyomatosis and tuberous sclerosis-related lymphangioleiomyomatosis.
The registry had six major clinical centers: Cleveland Clinic Foundation, Mayo Clinic-Rochester, National Heart, Lung, and Blood Institute, National Jewish Medical and Research Center, New England Medical Center, and Stanford University Medical Center. Data and lung tissue collected by the registry were collected to characterize the clinical features and natural history of the disease and to determine the efficacy of lung transplantation in this disorder. Eligible patients were seen yearly for up to 4 years at the Clinical Centers or, in some cases, by individual referring physicians. Tissue collected by the LAM Registry was stored at a central NHLBI repository. Outcome events included measures of pulmonary function (eg, spirometry and, when available, lung volumes and diffusing capacity), arterial blood gases or oximetry, walking and resting oxygen titration, cardiopulmonary stress testing, cause-specific mortality, functional status, and clinical events associated with lung transplantation.
Resources AvailableSpecimens and Study Datasets
- Buffy Coat
- There is no Data Dictionary associated with this study.
Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.